Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifabutin for MAC Prevention in AIDS
NCT00002267Phase 3Completed
- Sponsor
- Pharmacia
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in Mycobacterium avium complex infection (MAC) comparing Rifabutin with Placebo (2 arms). Primary endpoints: Incidence of Mycobacterium avium complex (MAC) bacteremia and Safety assessment. Status: completed.
02
Drugs
rifabutin
03
Conditions
Mycobacterium avium complex infection (MAC)
Beyond the preview
Go deeper on NCT00002267.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002267.